The highest price of Baroda Extrusion Ltd stock is ₹15.02 in the last 52-week. What is the share price of Baroda Extrusion Ltd () today on BSE? As on Jan 24, 2025, Baroda Extrusion Ltd ()’s ...

Golkonda Aluminium Extrusions Limited was originally incorporated on 22nd August 1988 under the name of Progressive Aluminium Limited to produce extrusions and went into production in 1991. In ...

If you're just starting to invest, many top brokerages offer free stock-trading platforms that can get you started. They offer zero-commission trading and no account minimums, making investing ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Leverage fair value analysis to evaluate the market value of stocks enabling more informed investment decisions.

Sensex, Nifty Crashed By 0.5-1% From Jan 20-24; What To Expect In Indian Stock Market Next Week? Sensex, Nifty In Big Rally: What Is Driving Bulls In Indian Stock Market On January 24? Closing ...

Baroda Extrusion Limited was incorporated in year 1991. The Company is the first Copper extrusion plant in India having excellent infrastructure and facilities in house. The manufacturing plant is ...

Kena Betancur -VIEWpress / Getty Images U.S. stock futures are pointing higher ahead of a closely watched inflation report; JPMorgan Chase (JPM) shares are moving higher after fourth-quarter ...

Spencer Platt / Getty Images When it comes to investing, deciding when to buy a stock can sometimes be easier than knowing when to sell it. Buy recommendations are prevalent and stem from a wide ...

Mesoblast shares fell about 7% after a $260m placement following FDA approval for its cell therapy treatment remestemcel-L in December. Don't miss out on the headlines from Stockhead. Followed ...

Mesoblast shares fall ~7% after a $260 million placement following FDA approval for its cell therapy treatment remestemcel-L in December Atomo Diagnostics inks a five-year $5.44 million deal with ...